Stocktoria
Ascend Wellness Holdings, Inc. AAWH
OTC · OOTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2021-05-04
Ascend Wellness Holdings, Inc. financials (annual, from 10-K)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $500.6M | $561.6M | $518.6M | $405.9M | $332.4M | $143.7M |
| Gross profit | $169.7M | $184.2M | $155.1M | $134.6M | $136.0M | $60.9M |
| Operating income | -$17.0M | $4.7M | -$3.6M | -$7.5M | -$17.2M | $7.8M |
| Interest expense | — | — | $37.0M | $32.4M | $64.0M | $13.0M |
| Income tax | $51.4M | $45.2M | $33.5M | $41.7M | $41.7M | $18.7M |
| Net income | — | — | — | -$80.9M | -$122.7M | -$25.4M |
| EPS (diluted) | $-0.58 | $-0.40 | $-0.24 | $-0.44 | $-0.82 | $-0.27 |
| Operating cash flow | $38.1M | $73.3M | $75.3M | -$38.4M | -$41.7M | -$6.0M |
| Free cash flow | $12.0M | $50.8M | $51.1M | -$120.0M | -$130.2M | -$32.4M |
| Cash & equivalents | $85.7M | $88.3M | $72.5M | $74.1M | $155.5M | $56.5M |
| Inventory | $84.7M | $89.6M | $95.3M | $97.5M | $65.6M | $29.0M |
| Total assets | $907.9M | $900.4M | $919.5M | $872.2M | $723.4M | $427.7M |
| Total liabilities | $954.5M | $828.6M | $776.7M | $708.7M | $547.0M | $424.0M |
| Shareholders' equity | -$47.4M | $71.8M | $142.9M | $163.4M | $176.5M | $3.8M |
Growth · year-over-year · Revenue CAGR 28.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue growth | -10.9% | +8.3% | +27.8% | +22.1% | +131.3% | — |
| Free cash flow growth | -76.3% | -0.6% | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001756390 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.